Vor Biopharma issues Pre-Funded Warrants to RemeGen
Vor Biopharma agreed to issue Pre-Funded Warrants to RemeGen for up to 2.3 million shares as consideration under a Securities Purchase and License Agreement. The event impacts the company’s capital structure and cap table.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed